Cognex is the IBD Stock Of The Day as the machine vision specialist is seen as a winner in the industrial automation trend.

D.A. Davidson upgraded Palantir stock to buy from neutral on views that it's a better option for enterprises than OpenAI or Anthropic.

AbbVie’s $10.9B Apogee deal strengthens immunology beyond Humira, adds Zumilokibart optionality, and may be undervalued. See ...

A systematic review found that creatine may help ease depressive symptoms when added to standard treatment, but trial results ...

Treatment for many gastrointestinal cancers is becoming increasingly personalized, thanks to advances in genetic research, targeted therapies and a deeper understanding of how individual tumors behave ...

Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing ...

Abivax SA Sponsored ADR ( (ABVX)) has shared an update. On May 4, 2026, Abivax SA agreed to repurchase all outstanding royalty certificates issued in 2022 from existing holders for a total of $90 ...

Spyre Therapeutics is building a long-acting antibody platform across IBD and rheumatology. Read why I only rate SYRE stock a ...

Allegro MicroSystems, Inc. (NASDAQ:ALGM) is one of the High Growth Semiconductor Stocks to Buy Now. Allegro MicroSystems, Inc ...

(All times Eastern) ...